Document is current
Any future updates will be listed below
-
Authors
Al-Mekhlafi, Hesham M. https://orcid.org/0000-0003-2582-7410
Madkhali, Aymen M.
Ghailan, Khalid Y.
Abdulhaq, Ahmed A.
Ghzwani, Ahmad Hassn
Zain, Khalid Ammash
Atroosh, Wahib M.
Alshabi, Alkhansa
Khadashi, Hussein A.
Darraj, Majid A.
Eisa, Zaki M.
-
Funding
Funding for this research was provided by:
Jazan University (JUP8//000250)
- License Information
-
More Information
Article History
Received: 6 January 2021
Accepted: 6 July 2021
First Online: 13 July 2021
Declarations
:
: This study was approved by the Research Ethics Committee of Jazan University (Ref. No. REC39/6-250) as well as by the Health Affairs Directorate of King Fahd Central Hospital, Jazan, Saudi Arabia (Registry No. 086), the respective local official authorities. The objectives and procedures of the study were explained to the patients presented at the health facilities. Then, written and signed informed consents were obtained from all adult participants and parents/guardians on behalf of their children. On the other hand, data collected from health facilities were derived from routine laboratory investigations data of the respective health facilities. Patient names have been anonymized and informed consents were not obtained. All malaria-positive individuals were treated at the respective healthcare facility with the standard medication according to the national malaria drug policy.
: Not applicable.
: The authors declare that they have no competing interests.
